Hostname: page-component-7479d7b7d-68ccn Total loading time: 0 Render date: 2024-07-13T13:23:34.864Z Has data issue: false hasContentIssue false
  • English
  • Français

Epidemiology, Diagnosis, and Therapy of Fungal Infections in Surgery

Published online by Cambridge University Press:  02 January 2015

Helen Giamarellou  and
Anastasia Antoniadou
Helen Giamarellou
Affiliation:
Athens University School of Medicine, First Department of Propedeutic Medicine, Laiko General Hospital, Athens, Greece
Anastasia Antoniadou
Affiliation:
Athens University School of Medicine, First Department of Propedeutic Medicine, Laiko General Hospital, Athens, Greece
Get access Rights & Permissions [Opens in a new window]

Abstract

Over the past decade, the incidence of hospital-acquired bloodstream infections caused by Candida strains has risen, while the implicated species have changed. Candida tropicalis, Candida parapsilosis, and Candida glabrata all have increased in incidence. Data from the Centers for Disease Control and Prevention reveal that, between 1980 and 1990, Candida emerged as the sixth most common nosocomial pathogen (7.2.%) and was the fourth most common pathogen in nosocomial bloodstream infections, surpassed only by coagulase-negative staphylococci, Staphylococcus aureus, and enterococci. The incidence of candidemia is dramatically higher in high-risk critical-care units: 25% of cases occur in surgical intensive-care units (ICUs) versus 25% in bone marrow transplantation units, 20% in medical ICUs, 20% in general medical wards, and 10% in oncology-hematology units. Burns and gastrointestinal surgery predispose to nosocomial candidemia. Independent risk factors include prior therapy with multiple antibiotics, isolation of Candida from sites other than blood, and prior hemodialysis. Crude mortality exceeds 55% and is associated with older age and concomitant renal failure, hepatic failure, acute respiratory diseases, or postoperative shock. In addition to extreme vigilance for early recognition of Candida sepsis in critically ill surgical patients, the high risk for candidemia probably necessitates fungal surveillance cultures and initiation of preemptive antifungal therapy in high-risk surgical patients.

Type
From the Fourth International Conference on the Prevention of Infection
Information
Infection Control & Hospital Epidemiology , Volume 17 , Issue 8 , August 1996 , pp. 558 - 564
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Banerjee, SN, Emori, TG, Culver, DH, the National Nosocomial Infections Surveillance System, et al. Secular trends in nosocomial primary bloodstream infections in the United States 1980-1990. Am J Med 1991;92(suppl 3B):86–89.Google Scholar
2. Jarvis, WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995;20:1526–1530.Google Scholar
3. Fraser, VJ, Jones, M, Dunkel, J, Storfer, S, Medoff, G, Dunagan, WC. Candidemia in a tertiary care hospital: epidemiology risk factors and predictors of mortality. Clin Infect Dis 1992;15:414–421.Google Scholar
4. Komshian, SV, Uwaydah, AK, Sob, JD, Crane, LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patients: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989;11:379–390.Google Scholar
5. Taylor, GD, Buchanan-Chell, M, Kirkland, T, McKenzie, M, Wiens, R. Trends and sources of nosocomial fungaemia. Mycoses 1994;37:187–199.Google Scholar
6. Anaissie, E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 1992;14(suppl 1):43–53.Google Scholar
7. Becker WK, Cioffiwg, McManus, AT, et al. Fungal burn wound infection. Arch Surg 1991;126:44–48.Google Scholar
8. Gaines, JD, Remington, JS. Disseminated candidiasis in the surgical patient. Surgery 1972;72:730–736.Google Scholar
9. Edwards, JE. Invasive Candida infections-evolution of a fungal pathogen. N Engl J Med 1991;324:1060–1062.Google Scholar
10. Buchard, KW, Minor, LB, Slotman, GJ, Gann, DS. Fungal sepsis in surgical patients. Arch Surg 1983;118:217–221.Google Scholar
11. Kusne, S, Dummer, JS, Singh, N, et al. Infections after liver transplantation: an analysis of 101 consecutive cases. Medicine 1988;67:132–143.Google Scholar
12. Alden, SM, Frank, E, Flanchaum, L. Abdominal candidiasis in surgical patients. Am Surg 1989;55:45–49.Google Scholar
13. Castaldo, P, Stratta, RJ, Wood, P, et al. Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg 1991;126:149–156.Google Scholar
14. Kujath, P. Fungal infections in surgical patients. Mycoses 1992;35:225–228.Google Scholar
15. Eubanks, PJ, de Virgilio, C, Klein, S, Bongard, F. Candida sepsis in surgical patients. Am J Surg 1993;166:617–620.CrossRefGoogle ScholarPubMed
16. Vindenes, H, Bjerknes, R. The frequency of bacteremia and fungemia following wound cleaning and excision in patients with large burns. J Trauma 1993;35:742–749.CrossRefGoogle ScholarPubMed
17. Cornwell, E, Belzberg, H, Berne, TV, et al. The pattern of fungal infections in critically ill surgical patients. Am Surg 1995;61:847–850.Google Scholar
18. Wenzel, RP. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis 1995;20:1531–1534.Google Scholar
19. Price, MF, LaRocco, MT, Gentry, LO. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob Agents Chemother 1994;38:1422–1424.Google Scholar
20. Richet, HM, Andremont, A, Tanerede, C, Pico, JL, Jarvis, WR. Risk factors for candidemia in patients with acute lymphocytic leukemia. Rev Infect Dis 1991;13:211–215.Google Scholar
21. Miller, PJ, Wenzel, RP. Etiologic organisms as independent predictors of death and morbidity associated with bloodstream infections. J Infect Dis 1987;156:471–477.Google Scholar
22. Wey, SB, Mori, M, Pfaller, MA, Woolson, RF, Wenzel, RP. Hospital acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642–2645.Google Scholar
23. Vincent, JL, Bihari, DJ, Suter, PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. JAMA 1995;274:639–644.Google Scholar
24. Varquez, JA, Sanchez, V, Dmuchowski, C, Dembry, LM, Sobel, JD, Zervos, MJ. Nosocomial acquisition of Candida albicans: an epidemiologic study. J Infect Dis 1993;168:195–201.Google Scholar
25. Lee, W, Burnie, JP, Matthews, RC, Oppenheim, BO, Damani, NN. Hospital outbreaks with yeasts. J Hosp Infect 1991;18(suppl A):237–249.Google Scholar
26. Pfaller, MA. Epidemiology and control of fungal infections. Clin Infect Dis 1994;19(S1):8–13.Google Scholar
27. Pittet, D, Monod, F, Filthuth, I, Frenk, E, Suter, PM, Auckenthaler, R. Contour-clamped homogenous electric field gel electrophoresis as a powerful epidemiologic tool in yeast infections. Am J Med 1991;91(3B):256–263.Google Scholar
28. Rangel-Fausto, MS, Martin, MA, Saiman, L, et al. High-Prevalence of Candida species on Hands of Health Care Workers (HCWs) in Surgical (S) and Neonatal (N) Intensive Care Units (ICUs): A Multicenter study. The 34th Interscience Conference on Antimicrobial Agents and Chemotherapy; Orlando, FL; 1994. Abstract J 106.Google Scholar
29. Doebbeling, BN, Stanley, GL, Sheetz, CT, et al. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 1992;327:88–93.Google Scholar
30. Rantala, A, Niinikoski, J, Lehtonen, OP. Pathogenesis of postoperative candidiasis: no detectable fungemia during reoperations after abdominal surgery. Mycoses 1990;34:47–52.Google Scholar
31. Ghannoum, MA, Abu-Elteen, KH. Pathogenicity determinants of Candida . Mycoses 1990;33:265–282.CrossRefGoogle ScholarPubMed
32. Calderone, RA. Host parasite relationships in candidiasis. Mycoses 1989;32(suppl 2):12–17.Google Scholar
33. Inone, S, Wirman, JA, Alexander, JW, Trocki, O, Cardel, RR. Candida albicans translocation across the gut mucosa following burn injury. J Surg Res 1988;44:479–492.CrossRefGoogle Scholar
34. Deitch, EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 1990;125:403–404.CrossRefGoogle ScholarPubMed
35. Wey, SB, Mori, M, Pfaller, MA, Woolson, RF, Wenzel, RP. Risk factors for hospital-acquired candidemia. Arch Intern Med 1989;149:2349–2353.Google Scholar
36. Bross, J, Talbot, GH, Maislin, G, Hurqitz, S, Strom, BL. Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. Am J Med 1989;87:614–620.Google Scholar
37. Slotman, GJ, Shapiro, E, Moffa, SM. Fungal sepsis: multisite colonization versus fungemia. Am Surg 1994;60:107–113.Google Scholar
38. Pittet, D, Monod, M, Suter, PM, Frenk, G, Auckenthaler, R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994;6:751–758.Google Scholar
39. Thomson, SR, Bade, PG, Taams, M, Chrystal, V. Gastrointestinal mucormycosis. Br J Surg 1991;78:952–954.Google Scholar
40. Lehrer, RI, Howard, DH, Sypherd, PS, Edwards, JE, Segal, GP, Winston, DJ. Mucormycosis. Ann Intern Med 1980;93:93–108.CrossRefGoogle Scholar
41. Editorial. Mucormycosis. Lancet 1986;I:1362–1363.Google Scholar
42. Hiatt, JR, Kobayashi, MR, Doty, JE, Ramming, KP. Acalculous Candida cholecystitis: a complication of critical surgical illness. Am Surg 1991;57:825–829.Google Scholar
43. Wiesenfeld, HC, Berg, SR, Sweet, RL. Torulopsis glabrata pelvic abscess and fungemia. Obstet Gynecol 1994;83:887–889.Google Scholar
44. Pittet, D, Anaissie, E, Solomkin, JS. When to start antifungal therapy in the non-neutropenic critically ill? In: Vincent, JL, ed. Yearbook of Intensive Care and Emergency Medicine. Heidelberg, NY: Springer-Verlag Berlin Heidelberg Inc;1996:567–577.Google Scholar
45. Edwards, JEJ, Filler, SG. Current strategies for treating invasive candidiasis: emphasis on infections in non-neutropenic patients. Clin Infect Dis 1992;I:14(S1):106–113.Google Scholar
46. Matthews, RC, Burnie, JP. New developments in the serological diagnosis of Candida infections. Mycoses 1983;31(suppl 2):34–38.Google Scholar
47. Jones, JM. Laboratory diagnosis of invasive candidiasis. Clin Microbiol Rev 1990;3:32–45.Google Scholar
48. McNeill, MM, Gerber, AR, McLaughlin, DW, et al. Man antigenemia during invasive candidiasis caused by Candida tropicalis . Pediatr Infect Dis J 1992;II:493–496.Google Scholar
49. Reis, E, Morrison, CJ. Non culture methods for diagnosis of disseminated candidiasis. Clin Microbiol Rev 1993;6:311–323.Google Scholar
50. Makimura, K, Murayama, SY, Yamaguchi, H. Detection of a wide range of medically important fungi by the polymerase chain reaction. J Med Microbiol 1994;40:358–364.Google Scholar
51. Burnic, JP. Early diagnosis of systemic fungal infection. Curr Opin Infect Dis 1995;8:258–260.CrossRefGoogle Scholar
52. Reagan, DR, Pfaller, MA, Hollis, RJ, Wenzel, RP. Nosocomial candidemia: characterization of the sequence of colonization and infection using DNA fingerprinting and a DNA probe. J Clin Microbiol 1990;28:2732–2738.Google Scholar
53. Pfaller, MA. Epidemiology of fungal infections. The promise of molecular typing. Clin Infect Dis 1995;20:1535–1539.CrossRefGoogle ScholarPubMed
54. British Society for Antimicrobial Chemotherapy Working Party: management of deep Candida infection in surgical and intensive care unit patients. Intensive Care Med 1994;20:522–528.CrossRefGoogle Scholar
55. Solomkin, JS. Pathogenesis and management of Candida infections syndromes in non-neutropenic patients. New Horiz 1993;1:202–213.Google Scholar
56. Anaissie, E, Solomkin, JS. Fungal infection-approach to the surgical patient at risk for candidiasis. In: Wilmore, DW, Cheung, LY, Harken, AH, American College of Surgeons, eds. Scientific American Surgery. New York, NY: Scientific American, Inc; 1994:1–19.Google Scholar
57. Kujath, P, Lerch, K. New antimicrobial agents under clinical investigation. Secondary mycosis in surgery: treatment with fluconazole. Infection 1989;12:111–117.CrossRefGoogle Scholar
58. Nolla-Salas, J, Leon, C, Torres-Rodriguez, JM, Martin, E, Sitges-Serra, A. Treatment of candidemia in critically ill surgical patients with intravenous fluconazole. Clin Infect Dis 1992;14:952–954.Google Scholar
59. Graninger, W, Presteril, E, Schneeweis, B, Teleky, B, Georgopoulos, A. Treatment of Candida albicans fungaemia with fluconazole. J Infect 1992;26:133–146.Google Scholar
60. Kujath, P, Lerch, K, Kochendorfer, P, Boos, C. Comparative study of the efficacy of fluconazole versus amphotericin B/flucytosine in surgical patients with systemic mycoses. Infection 1993;21:28, 376-334, 382.Google Scholar
61. Nassoura, Z, Ivatury, RR, Simon, RJ, Jabbour, N, Stahl, WM. Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy. J Trauma 1993;35:290–294.Google Scholar
62. Anaissie, EJ, Darwiche, R, Mera, J, Gentry, L, Abi-Said, D, Bodey, GP. A prospective randomized multicenter study comparing fluconazole to amphotericin B for nosocomial candidiasis. The 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy; New Orleans, LA; 1993. Abstract 289.Google Scholar
63. Rex, JH, Bennett, JE, Sugar, AM, et al, for the Candidemia Study Group, the National Institute of Allergy and Infectious Diseases Mycoses Study Group. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994;331:1325–1330.Google Scholar
64. Rex, JH, Rinaldi, MG, Pfaller, MA. Resistance of Candida species to fluconazole. Antimicrob Agents Chemother 1995;39:1–8.Google Scholar